Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05442853 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients
A NA study, sponsored by Malcom Randall VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT05442853 is a NA study that has completed, run by Malcom Randall VA Medical Center. The registered enrollment target is 85 participants.
The verdict
NCT05442853, a NA study, has completed, sponsored by Malcom Randall VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The investigators intend to conduct a single-center, prospective, randomized comparative trial of patients admitted to the intensive care unit (ICU) who received continuous glucose monitoring (CGM) vs point of care (POC) glucose monitoring. The study will examine relevant outcomes for patients in the ICU with diabetes mellitus and/or hyperglycemia. The primary outcome of the study will be the proportion of time in target range (blood glucose 70-180 mg/dL).
Interventions
- DEVICE Continuous glucose monitoring
- DEVICE Point of care glucose monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05442853
The ClinicalTrials.gov registry entry for NCT05442853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Malcom Randall VA Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous glucose monitoring is the first listed.
NCT05442853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05442853 about?
NCT05442853 is a clinical study titled "Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients". The investigators intend to conduct a single-center, prospective, randomized comparative trial of patients admitted to the intensive care unit (ICU) who received continuous glucose monitoring (CGM) vs point of care (POC) glucose monitoring. The study will examine relevant outcomes for patients in th...
What is the current status of trial NCT05442853?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2023-04-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05442853?
The interventions under investigation include: Continuous glucose monitoring (DEVICE), Point of care glucose monitoring (DEVICE).
Who is sponsoring clinical trial NCT05442853?
This trial is sponsored by Malcom Randall VA Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.